Since VDR functions as a ligand‐activated transcription factor upon vitamin D binding, we hypothesized that we might observe that VDR would be inhibited in response to deficiencies in vitamin D, its canonical ligand, in the brains of humans with AD. Here, VDR is linked to Alzheimer disease.